United States Biotechnology & Medical Research

Eiger BioPharmaceuticals Inc (EIGR)

Track

Track

Ticker: EIGR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Eiger BioPharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
KAYNE RICHARD A Large shareholder
Transaction date
Purchase
Price
242.97
Quantity 41,565 +2.4%
Value US$4,036,520
2.2
KAYNE RICHARD A Large shareholder
Transaction date
Purchase
Price
384.97
Quantity 51,213 +13.0%
Value US$4,506,007
1.5
KAWAS LEEN Large shareholder
Transaction date
Purchase
Price
74.72
Quantity 57,459 +17.0%
Value US$2,917,720
1.5
KAWAS LEEN Large shareholder
Transaction date
Purchase
Price
0.26
Quantity 11,987 +0.3%
Value US$3,147
2.2
KAYNE RICHARD A Large shareholder
Transaction date
Purchase
Price
0.24
Quantity 130,509 +2.5%
Value US$31,505
2.2
KAYNE RICHARD A Large shareholder
Transaction date
Purchase
Price
0.26
Quantity 12,345 +0.2%
Value US$3,228
2.2
KAYNE RICHARD A Large shareholder
Transaction date
Purchase
Price
0.26
Quantity 11,987 +0.2%
Value US$3,147
0.7
Mayer Eldon C. III Ex VP & Chief Commerc. Officer Officer
Transaction date
Sale
Price
1.07
Quantity 1,875 -3.2%
Value US$2,008
0.7
Mayer Eldon C. III Ex VP & Chief Commerc. Officer Officer
Transaction date
Sale
Price
1.07
Quantity 2,520 -4.2%
Value US$2,696
1.7
Dietz Thomas John Non-Executive Director
Transaction date
Purchase
Price
1.43
Quantity 50,000 +inf%
Value US$71,580
2.2
Murray Christine Non-Executive Director
Transaction date
Sale
Price
1.22
Quantity 5,000 -31.2%
Value US$6,104
3.4
Glenn Jeffrey S Non-Executive Director
Transaction date
Purchase
Price
1.28
Quantity 100,000 +121.4%
Value US$127,950
1.7
Dietz Thomas John Non-Executive Director
Transaction date
Sale
Price
1.17
Quantity 22,500 -51.7%
Value US$26,302
Apelian David Non-Executive Director
Transaction date
Planned sale
Price
9.81
Quantity 5,000 -31.2%
Value US$49,030
0.7
Mayer Eldon C. III Ex VP & Chief Commerc. Officer Officer
Transaction date
Sale
Price
5.60
Quantity 1,657 -2.7%
Value US$9,275
2.7
Ryali Sriram Chief Financial Officer Officer
Transaction date
Sale
Price
5.60
Quantity 2,266 -5.2%
Value US$12,683
0.7
Mayer Eldon C. III Ex VP & Chief Commerc. Officer Officer
Transaction date
Sale
Price
4.95
Quantity 1,560 -3.3%
Value US$7,722
2.8
Loh Evan Non-Executive Director
Transaction date
Sale
Price
10.14
Quantity 2,000 -20.0%
Value US$20,280
0.7
Mayer Eldon C. III Ex VP & Chief Commerc. Officer Officer
Transaction date
Sale
Price
11.68
Quantity 1,690 -4.5%
Value US$19,739
3.4
Glenn Jeffrey S Non-Executive Director
Transaction date
Purchase
Price
11.44
Quantity 4,500 +900.0%
Value US$51,465
3.4
Glenn Jeffrey S Non-Executive Director
Transaction date
Purchase
Price
11.28
Quantity 500 +inf%
Value US$5,638
3.4
Glenn Jeffrey S Non-Executive Director
Transaction date
Purchase
Price
11.49
Quantity 5,000 +7.5%
Value US$57,464
3.4
Glenn Jeffrey S Non-Executive Director
Transaction date
Purchase
Price
5.03
Quantity 30,000 +82.5%
Value US$150,813
1.7
Dietz Thomas John Non-Executive Director
Transaction date
Purchase
Price
4.95
Quantity 1,000 +3.4%
Value US$4,950
0.7
Mayer Eldon C. III Ex VP & Chief Commerc. Officer
Transaction date
Purchase
Price
13.52
Quantity 5,000 +20.0%
Value US$67,602
1.7
Dietz Thomas John
Transaction date
Purchase
Price
13.94
Quantity 4,000 +20.0%
Value US$55,760
1.7
Dietz Thomas John
Transaction date
Purchase
Price
11.10
Quantity 5,000 +33.3%
Value US$55,495
1.7
Patton Stephana Eilene See Remarks
Transaction date
Purchase
Price
11.03
Quantity 1,000 +33.3%
Value US$11,030
2.7
Ryali Sriram Chief Financial Officer
Transaction date
Purchase
Price
11.08
Quantity 1,250 +inf%
Value US$13,853
1.7
Dietz Thomas John
Transaction date
Purchase
Price
11.05
Quantity 5,000 +50.0%
Value US$55,250
0.7
Cory David A President and CEO Executive Director
Transaction date
Purchase
Price
11.26
Quantity 343 +0.5%
Value US$3,862
0.7
Cory David A President and CEO Executive Director
Transaction date
Purchase
Price
14.13
Quantity 227 +0.4%
Value US$3,208
Dietz Thomas John Non-Executive Director
Transaction date
Purchase
Price
9.98
Quantity 5,000 +100.0%
Value US$49,900
Dietz Thomas John Non-Executive Director
Transaction date
Purchase
Price
11.26
Quantity 5,000 +inf%
Value US$56,300
Mayer Eldon C. III Non-Executive Director
Transaction date
Purchase
Price
10.21
Quantity 4,000 +19.0%
Value US$40,840
Mayer Eldon C. III Non-Executive Director
Transaction date
Purchase
Price
9.92
Quantity 7,500 +100.0%
Value US$74,408
Mayer Eldon C. III Non-Executive Director
Transaction date
Purchase
Price
9.75
Quantity 7,500 +inf%
Value US$73,143
INTERWEST PARTNERS X LP Large shareholder
Transaction date
Sale
Price
12.00
Quantity 26,465 -1.9%
Value US$317,606
INTERWEST PARTNERS X LP Large shareholder
Transaction date
Sale
Price
12.07
Quantity 210,800 -13.2%
Value US$2,544,714
Quan Joanne Chief Medical Officer
Transaction date
Sale
Price
10.00
Quantity 4,000 -100.0%
Value US$40,000
Glenn Jeffrey S
Transaction date
Purchase
Price
9.53
Quantity 15,000 +91.7%
Value US$142,950
Glenn Jeffrey S Non-Executive Director
Transaction date
Purchase
Price
12.90
Quantity 460 +inf%
Value US$5,934
Glenn Jeffrey S Non-Executive Director
Transaction date
Purchase
Price
12.73
Quantity 15,000 +1107.0%
Value US$190,950
Vivo Ventures VI, LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,364 +11.7%
Value US$21,824
Vivo Ventures VI, LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 186,136 +11.7%
Value US$2,978,176
Cory David A President and CEO Executive Director
Transaction date
Purchase
Price
15.70
Quantity 1,562 +2.7%
Value US$24,523
Shaffer James P Chief Business Officer Officer
Transaction date
Purchase
Price
15.70
Quantity 3,125 +125.3%
Value US$49,062
WELCH JAMES H Chief Financial Officer Officer
Transaction date
Purchase
Price
19.79
Quantity 500 +25.0%
Value US$9,897
WELCH JAMES H Chief Financial Officer Officer
Transaction date
Purchase
Price
19.80
Quantity 2,000 +inf%
Value US$39,592
Shaffer James P Chief Business Officer Officer
Transaction date
Purchase
Price
22.20
Quantity 420 +20.2%
Value US$9,324
Shaffer James P Chief Business Officer Officer
Transaction date
Purchase
Price
22.17
Quantity 100 +5.1%
Value US$2,217
Shaffer James P Chief Business Officer Officer
Transaction date
Purchase
Price
22.16
Quantity 730 +58.6%
Value US$16,177
Shaffer James P Chief Business Officer Officer
Transaction date
Purchase
Price
19.99
Quantity 745 +149.0%
Value US$14,893
Shaffer James P Chief Business Officer Officer
Transaction date
Purchase
Price
19.52
Quantity 500 +inf%
Value US$9,760
ZSEBO KRISZTINA M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.44
Quantity 6,629 -68.0%
Value US$122,239
ZSEBO KRISZTINA M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.16
Quantity 41,302 -80.9%
Value US$750,044
LABA REBECQUE J VP, Corporate Operations Officer
Transaction date
Planned sale
Price
16.95
Quantity 1,012 -25.9%
Value US$17,153
LABA REBECQUE J VP, Corporate Operations Officer
Transaction date
Planned sale
Price
17.33
Quantity 10,000 -71.9%
Value US$173,300
TAKEYA RYAN K VP, Manufacturing Officer
Transaction date
Planned sale
Price
19.13
Quantity 4,444 -75.6%
Value US$85,014
ZSEBO KRISZTINA M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
24.71
Quantity 6,629 -68.0%
Value US$163,803
ZSEBO KRISZTINA M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
24.81
Quantity 41,302 -80.9%
Value US$1,024,703
Honig Peter Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 5,000 -100.0%
Value US$125,000
LABA REBECQUE J VP, Corporate Operations Officer
Transaction date
Planned sale
Price
22.48
Quantity 4,000 -58.0%
Value US$89,920
LABA REBECQUE J VP, Corporate Operations Officer
Transaction date
Planned sale
Price
23.29
Quantity 10,000 -59.2%
Value US$232,900
Honig Peter Non-Executive Director
Transaction date
Planned sale
Price
22.29
Quantity 2,200 -100.0%
Value US$49,038
Honig Peter Non-Executive Director
Transaction date
Planned sale
Price
22.50
Quantity 2,500 -53.2%
Value US$56,250
TAKEYA RYAN K VP, Manufacturing Officer
Transaction date
Planned sale
Price
18.48
Quantity 7,777 -84.4%
Value US$143,719
ZSEBO KRISZTINA M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.94
Quantity 6,629 -68.0%
Value US$105,666
ZSEBO KRISZTINA M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.85
Quantity 41,302 -80.9%
Value US$654,637
LABA REBECQUE J VP, Corporate Operations Officer
Transaction date
Planned sale
Price
16.08
Quantity 4,000 -58.0%
Value US$64,320
LABA REBECQUE J VP, Corporate Operations Officer
Transaction date
Planned sale
Price
16.08
Quantity 10,000 -59.2%
Value US$160,800
TAKEYA RYAN K VP, Manufacturing Officer
Transaction date
Planned sale
Price
16.35
Quantity 7,777 -84.4%
Value US$127,154
RUDY JEFFREY J VP, Clinical Operations Officer
Transaction date
Planned sale
Price
18.51
Quantity 10,000 -90.7%
Value US$185,100
LABA REBECQUE J VP, Corporate Operations Officer
Transaction date
Planned sale
Price
17.30
Quantity 20,000 -87.4%
Value US$346,000
ZSEBO KRISZTINA M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
17.51
Quantity 41,302 -93.0%
Value US$723,198
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-02 2023-11-02 B Purchase
2.2
KAYNE RICHARD A
Large shareholder
41,565 +2.4%
242.97
US$4,036,520 		41,565 +2.4% 242.97 US$4,036,520
2023-11-02 2023-11-01 B Purchase
2.2
KAYNE RICHARD A
Large shareholder
51,213 +13.0%
384.97
US$4,506,007 		51,213 +13.0% 384.97 US$4,506,007
2023-11-02 2023-10-31 B Purchase
1.5
KAWAS LEEN
Large shareholder
57,459 +17.0%
74.72
US$2,917,720 		57,459 +17.0% 74.72 US$2,917,720
2023-11-02 2023-10-31 B Purchase
1.5
KAWAS LEEN
Large shareholder
11,987 +0.3%
0.26
US$3,147 		11,987 +0.3% 0.26 US$3,147
2023-11-02 2023-10-31 B Purchase
2.2
KAYNE RICHARD A
Large shareholder
130,509 +2.5%
0.24
US$31,505 		130,509 +2.5% 0.24 US$31,505
2023-11-02 2023-10-31 B Purchase
2.2
KAYNE RICHARD A
Large shareholder
12,345 +0.2%
0.26
US$3,228 		12,345 +0.2% 0.26 US$3,228
2023-11-02 2023-10-31 B Purchase
2.2
KAYNE RICHARD A
Large shareholder
11,987 +0.2%
0.26
US$3,147 		11,987 +0.2% 0.26 US$3,147
2023-03-21 2023-03-17 S Sale
0.7
Mayer Eldon C. III

Ex VP & Chief Commerc. Officer

Officer
1,875 -3.2%
1.07
US$2,008 		1,875 -3.2% 1.07 US$2,008
2023-03-21 2023-03-17 S Sale
0.7
Mayer Eldon C. III

Ex VP & Chief Commerc. Officer

Officer
2,520 -4.2%
1.07
US$2,696 		2,520 -4.2% 1.07 US$2,696
2023-01-25 2023-01-23 B Purchase
1.7
Dietz Thomas John
Non-Executive Director
50,000 +inf%
1.43
US$71,580 		50,000 +inf% 1.43 US$71,580
2023-01-03 2022-12-29 S Sale
2.2
Murray Christine
Non-Executive Director
5,000 -31.2%
1.22
US$6,104 		5,000 -31.2% 1.22 US$6,104
2022-12-27 2022-12-22 B Purchase
3.4
Glenn Jeffrey S
Non-Executive Director
100,000 +121.4%
1.28
US$127,950 		100,000 +121.4% 1.28 US$127,950
2022-12-27 2022-12-22 S Sale
1.7
Dietz Thomas John
Non-Executive Director
22,500 -51.7%
1.17
US$26,302 		22,500 -51.7% 1.17 US$26,302
2022-08-18 2022-08-16 PlS Planned sale
Apelian David
Non-Executive Director
5,000 -31.2%
9.81
US$49,030 		5,000 -31.2% 9.81 US$49,030
2022-03-14 2022-03-14 S Sale
0.7
Mayer Eldon C. III

Ex VP & Chief Commerc. Officer

Officer
1,657 -2.7%
5.60
US$9,275 		1,657 -2.7% 5.60 US$9,275
2022-03-14 2022-03-14 S Sale
2.7
Ryali Sriram

Chief Financial Officer

Officer
2,266 -5.2%
5.60
US$12,683 		2,266 -5.2% 5.60 US$12,683
2022-01-11 2022-01-07 S Sale
0.7
Mayer Eldon C. III

Ex VP & Chief Commerc. Officer

Officer
1,560 -3.3%
4.95
US$7,722 		1,560 -3.3% 4.95 US$7,722
2021-03-15 2021-03-15 S Sale
2.8
Loh Evan
Non-Executive Director
2,000 -20.0%
10.14
US$20,280 		2,000 -20.0% 10.14 US$20,280
2021-01-11 2021-01-08 S Sale
0.7
Mayer Eldon C. III

Ex VP & Chief Commerc. Officer

Officer
1,690 -4.5%
11.68
US$19,739 		1,690 -4.5% 11.68 US$19,739
2020-08-12 2020-08-12 B Purchase
3.4
Glenn Jeffrey S
Non-Executive Director
4,500 +900.0%
11.44
US$51,465 		4,500 +900.0% 11.44 US$51,465
2020-08-12 2020-08-12 B Purchase
3.4
Glenn Jeffrey S
Non-Executive Director
500 +inf%
11.28
US$5,638 		500 +inf% 11.28 US$5,638
2020-08-12 2020-08-11 B Purchase
3.4
Glenn Jeffrey S
Non-Executive Director
5,000 +7.5%
11.49
US$57,464 		5,000 +7.5% 11.49 US$57,464
2020-03-17 2020-03-16 B Purchase
3.4
Glenn Jeffrey S
Non-Executive Director
30,000 +82.5%
5.03
US$150,813 		30,000 +82.5% 5.03 US$150,813
2020-03-17 2020-03-16 B Purchase
1.7
Dietz Thomas John
Non-Executive Director
1,000 +3.4%
4.95
US$4,950 		1,000 +3.4% 4.95 US$4,950
2020-01-30 2020-01-24 B Purchase
0.7
Mayer Eldon C. III

Ex VP & Chief Commerc. Officer
5,000 +20.0%
13.52
US$67,602 		5,000 +20.0% 13.52 US$67,602
2020-01-13 2020-01-10 B Purchase
1.7
Dietz Thomas John
4,000 +20.0%
13.94
US$55,760 		4,000 +20.0% 13.94 US$55,760
2019-04-23 2019-04-23 B Purchase
1.7
Dietz Thomas John
5,000 +33.3%
11.10
US$55,495 		5,000 +33.3% 11.10 US$55,495
2019-04-22 2019-04-22 B Purchase
1.7
Patton Stephana Eilene

See Remarks
1,000 +33.3%
11.03
US$11,030 		1,000 +33.3% 11.03 US$11,030
2019-04-22 2019-04-22 B Purchase
2.7
Ryali Sriram

Chief Financial Officer
1,250 +inf%
11.08
US$13,853 		1,250 +inf% 11.08 US$13,853
2019-04-22 2019-04-22 B Purchase
1.7
Dietz Thomas John
5,000 +50.0%
11.05
US$55,250 		5,000 +50.0% 11.05 US$55,250
2019-04-26 2019-02-04 B Purchase
0.7
Cory David A

President and CEO

Executive Director
343 +0.5%
11.26
US$3,862 		343 +0.5% 11.26 US$3,862
2019-02-06 2019-02-04 B Purchase
0.7
Cory David A

President and CEO

Executive Director
227 +0.4%
14.13
US$3,208 		227 +0.4% 14.13 US$3,208
2018-12-20 2018-12-20 B Purchase Dietz Thomas John Non-Executive Director
5,000 +100.0%
9.98
US$49,900 		5,000 +100.0% 9.98 US$49,900
2018-12-10 2018-12-06 B Purchase Dietz Thomas John Non-Executive Director
5,000 +inf%
11.26
US$56,300 		5,000 +inf% 11.26 US$56,300
2018-11-30 2018-11-29 B Purchase Mayer Eldon C. III Non-Executive Director
4,000 +19.0%
10.21
US$40,840 		4,000 +19.0% 10.21 US$40,840
2018-11-28 2018-11-27 B Purchase Mayer Eldon C. III Non-Executive Director
7,500 +100.0%
9.92
US$74,408 		7,500 +100.0% 9.92 US$74,408
2018-11-28 2018-11-26 B Purchase Mayer Eldon C. III Non-Executive Director
7,500 +inf%
9.75
US$73,143 		7,500 +inf% 9.75 US$73,143
2018-10-22 2018-10-18 S Sale INTERWEST PARTNERS X LP Large shareholder
26,465 -1.9%
12.00
US$317,606 		26,465 -1.9% 12.00 US$317,606
2018-10-22 2018-10-18 S Sale INTERWEST PARTNERS X LP Large shareholder
210,800 -13.2%
12.07
US$2,544,714 		210,800 -13.2% 12.07 US$2,544,714
2018-04-04 2018-04-02 S Sale Quan Joanne

Chief Medical Officer
4,000 -100.0%
10.00
US$40,000 		4,000 -100.0% 10.00 US$40,000
2017-09-05 2017-09-01 B Purchase Glenn Jeffrey S
15,000 +91.7%
9.53
US$142,950 		15,000 +91.7% 9.53 US$142,950
2016-11-21 2016-11-18 B Purchase Glenn Jeffrey S Non-Executive Director
460 +inf%
12.90
US$5,934 		460 +inf% 12.90 US$5,934
2016-11-21 2016-11-17 B Purchase Glenn Jeffrey S Non-Executive Director
15,000 +1107.0%
12.73
US$190,950 		15,000 +1107.0% 12.73 US$190,950
2016-08-22 2016-08-18 B Purchase Vivo Ventures VI, LLC Large shareholder
1,364 +11.7%
16.00
US$21,824 		1,364 +11.7% 16.00 US$21,824
2016-08-22 2016-08-18 B Purchase Vivo Ventures VI, LLC Large shareholder
186,136 +11.7%
16.00
US$2,978,176 		186,136 +11.7% 16.00 US$2,978,176
2016-08-19 2016-08-18 B Purchase Cory David A

President and CEO

Executive Director
1,562 +2.7%
15.70
US$24,523 		1,562 +2.7% 15.70 US$24,523
2016-08-19 2016-08-18 B Purchase Shaffer James P

Chief Business Officer

Officer
3,125 +125.3%
15.70
US$49,062 		3,125 +125.3% 15.70 US$49,062
2016-06-22 2016-06-22 B Purchase WELCH JAMES H

Chief Financial Officer

Officer
500 +25.0%
19.79
US$9,897 		500 +25.0% 19.79 US$9,897
2016-06-22 2016-06-20 B Purchase WELCH JAMES H

Chief Financial Officer

Officer
2,000 +inf%
19.80
US$39,592 		2,000 +inf% 19.80 US$39,592
2016-06-14 2016-06-13 B Purchase Shaffer James P

Chief Business Officer

Officer
420 +20.2%
22.20
US$9,324 		420 +20.2% 22.20 US$9,324
2016-06-14 2016-06-13 B Purchase Shaffer James P

Chief Business Officer

Officer
100 +5.1%
22.17
US$2,217 		100 +5.1% 22.17 US$2,217
2016-06-14 2016-06-13 B Purchase Shaffer James P

Chief Business Officer

Officer
730 +58.6%
22.16
US$16,177 		730 +58.6% 22.16 US$16,177
2016-05-23 2016-05-23 B Purchase Shaffer James P

Chief Business Officer

Officer
745 +149.0%
19.99
US$14,893 		745 +149.0% 19.99 US$14,893
2016-05-23 2016-05-19 B Purchase Shaffer James P

Chief Business Officer

Officer
500 +inf%
19.52
US$9,760 		500 +inf% 19.52 US$9,760
2015-04-07 2015-04-06 PlS Planned sale ZSEBO KRISZTINA M

Chief Executive Officer

Executive Director
6,629 -68.0%
18.44
US$122,239 		6,629 -68.0% 18.44 US$122,239
2015-04-07 2015-04-06 PlS Planned sale ZSEBO KRISZTINA M

Chief Executive Officer

Executive Director
41,302 -80.9%
18.16
US$750,044 		41,302 -80.9% 18.16 US$750,044
2015-04-03 2015-04-02 PlS Planned sale LABA REBECQUE J

VP, Corporate Operations

Officer
1,012 -25.9%
16.95
US$17,153 		1,012 -25.9% 16.95 US$17,153
2015-04-03 2015-04-02 PlS Planned sale LABA REBECQUE J

VP, Corporate Operations

Officer
10,000 -71.9%
17.33
US$173,300 		10,000 -71.9% 17.33 US$173,300
2015-04-03 2015-04-01 PlS Planned sale TAKEYA RYAN K

VP, Manufacturing

Officer
4,444 -75.6%
19.13
US$85,014 		4,444 -75.6% 19.13 US$85,014
2015-03-09 2015-03-09 PlS Planned sale ZSEBO KRISZTINA M

Chief Executive Officer

Executive Director
6,629 -68.0%
24.71
US$163,803 		6,629 -68.0% 24.71 US$163,803
2015-03-09 2015-03-09 PlS Planned sale ZSEBO KRISZTINA M

Chief Executive Officer

Executive Director
41,302 -80.9%
24.81
US$1,024,703 		41,302 -80.9% 24.81 US$1,024,703
2015-03-09 2015-03-06 PlS Planned sale Honig Peter Non-Executive Director
5,000 -100.0%
25.00
US$125,000 		5,000 -100.0% 25.00 US$125,000
2015-03-09 2015-03-06 PlS Planned sale LABA REBECQUE J

VP, Corporate Operations

Officer
4,000 -58.0%
22.48
US$89,920 		4,000 -58.0% 22.48 US$89,920
2015-03-09 2015-03-06 PlS Planned sale LABA REBECQUE J

VP, Corporate Operations

Officer
10,000 -59.2%
23.29
US$232,900 		10,000 -59.2% 23.29 US$232,900
2015-03-09 2015-03-05 PlS Planned sale Honig Peter Non-Executive Director
2,200 -100.0%
22.29
US$49,038 		2,200 -100.0% 22.29 US$49,038
2015-03-09 2015-03-05 PlS Planned sale Honig Peter Non-Executive Director
2,500 -53.2%
22.50
US$56,250 		2,500 -53.2% 22.50 US$56,250
2015-03-03 2015-03-02 PlS Planned sale TAKEYA RYAN K

VP, Manufacturing

Officer
7,777 -84.4%
18.48
US$143,719 		7,777 -84.4% 18.48 US$143,719
2015-02-10 2015-02-09 PlS Planned sale ZSEBO KRISZTINA M

Chief Executive Officer

Executive Director
6,629 -68.0%
15.94
US$105,666 		6,629 -68.0% 15.94 US$105,666
2015-02-10 2015-02-09 PlS Planned sale ZSEBO KRISZTINA M

Chief Executive Officer

Executive Director
41,302 -80.9%
15.85
US$654,637 		41,302 -80.9% 15.85 US$654,637
2015-02-10 2015-02-06 PlS Planned sale LABA REBECQUE J

VP, Corporate Operations

Officer
4,000 -58.0%
16.08
US$64,320 		4,000 -58.0% 16.08 US$64,320
2015-02-10 2015-02-06 PlS Planned sale LABA REBECQUE J

VP, Corporate Operations

Officer
10,000 -59.2%
16.08
US$160,800 		10,000 -59.2% 16.08 US$160,800
2015-02-03 2015-02-02 PlS Planned sale TAKEYA RYAN K

VP, Manufacturing

Officer
7,777 -84.4%
16.35
US$127,154 		7,777 -84.4% 16.35 US$127,154
2015-01-12 2015-01-09 PlS Planned sale RUDY JEFFREY J

VP, Clinical Operations

Officer
10,000 -90.7%
18.51
US$185,100 		10,000 -90.7% 18.51 US$185,100
2015-01-08 2015-01-07 PlS Planned sale LABA REBECQUE J

VP, Corporate Operations

Officer
20,000 -87.4%
17.30
US$346,000 		20,000 -87.4% 17.30 US$346,000
2015-01-08 2015-01-06 PlS Planned sale ZSEBO KRISZTINA M

Chief Executive Officer

Executive Director
41,302 -93.0%
17.51
US$723,198 		41,302 -93.0% 17.51 US$723,198
Explore more

More insider trading research around Eiger BioPharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America